drugset / Trial / NCT01793649

A Phase 1 Study to Characterize the Effect of GS-5737 Enhancement of Mucociliary Clearance (MCC) in Healthy Subjects

NCT01793649

Phase 1 Terminated 7 enrolled Gilead Sciences
RandomizedCrossoverQuadruple-blindTreatment

Summary

This is a randomized, double-blind, cross-over, vehicle-controlled study to determine whether GS-5737 in 2.8% saline accelerates mucociliary clearance (MCC) in healthy subjects, compared to vehicle of 2.8% saline alone.

Timeline

Start
2012-10
Primary completion
2013-06
Completion
2013-06

Drugs

EvaluationDrugModalityDoseRoute
Subject IDREVLORIDE Small molecule 85 ug